Two new papers, published simultaneously in Nature Communications and led by researchers at McGill University, offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer, one rare and one common form.

Classified as: biochemistry, genomics, Goodman Cancer Research Centre, lung cancer, ovarian cancer, William Foulkes, genetic markers, Sidong Huang
Published on: 4 Feb 2019
A team from the Research Institute of McGill University Health Centre (RI-MUHC) in Montreal has joined forces with researchers at Johns Hopkins to bring screening and early detection of ovarian and uterine cancers one step closer to clinical implementation. Researchers developed a test that provides a safe and minimally invasive method for earlier diagnosis of ovarian and endometrial cancers.
Classified as: Lucy Gilbert, RI-MUHC, ovarian cancer, muhc, minimally invasive gynecologic surgery
Category:
Published on: 21 Mar 2018

A new study by McGill University’s Division of Cancer Epidemiology will test a revolutionary way of preventing the transmission of the human papillomavirus (HPV) through the use of a topical gel applied during sexual activity.

Classified as: ovarian cancer, HPV
Category:
Published on: 8 Jan 2013

A new discovery that sheds light on the genetic make up of ovarian cancer cells could explain why some women survive longer than others with this deadly disease. A multi-disciplinary team led by the Research Institute of the McGill University Health Centre (RI MUHC), in collaboration with the Lady Davis Institute of the Jewish General Hospital and the University of Montreal Hospital Research Centre, has identified genetic patterns in ovarian cancer tumours that help to differentiate patients based on the length of their survival after initial surgery. The study was published in the journal PLOS ONE. 

Classified as: muhc, ovarian cancer, patricia tonin
Category:
Published on: 26 Sep 2012
Back to top